Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors

被引:55
作者
Hudelist, G
Singer, CF
Manavi, M
Pischinger, K
Kubista, E
Czerwenka, K
机构
[1] Univ Vienna, Dept Obstet & Gynecol, Div Special Gynecol, A-1010 Vienna, Austria
[2] Univ Vienna, Ludwig Boltzmann Inst Clin Expt Oncol, A-1010 Vienna, Austria
[3] Univ Vienna, Dept Clin Pathol, Div Gynecopathol, A-1010 Vienna, Austria
关键词
breast cancer; ligands; receptor co-expression; type 1 growth factor receptors;
D O I
10.1023/A:1024929522376
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over-expression of members of the ErbB-receptor family has been associated with malignant transformation. The amplification of Her-2/neu in tumor tissue is now an established prognostic factor in breast cancer. In order to initiate signal transduction, ErbB-receptor monomers need to form homo- or heterodimers. The composition of these dimers is thought to influence both quality and quantity of downstream signaling pathways, and to determine the biological response. We have investigated the protein expression pattern of the four ErbB-receptors EGFR, Her-2/neu, Her-3 and Her-4, and correlated it with their putative ligands EGF, TGF-alpha and HRG in 74 women with invasive breast cancer. Using western blot-analysis on cell membrane isolates, we detected the co-expression of all four ErbB-family members in 79.7% of cases, and of all of the three investigated ligands in 82.4%. We did not observe a correlation between EGFR and Her-2/neu or Her-4 protein expression, EGFR and Her-3 ( p = 0.005), and Her-3 and Her-4 ( p = 0.05) were clearly co-expressed. The strongest overall correlation, was found between Her-2/neu and Her-3 ( p < 0.001) and between Her-2/neu and Her-4 ( p = 0.001). This was particularly true in nodal-positive tumors ( p < 0.001 and p = 0.002) whereas in nodal-negative tumors the co-expression was either less significant ( Her-2/neu and Her-3; p = 0.01) or not significant ( Her-2/neu and Her-4). The co-expression of EGFR/Her-3 was associated with the expression of all ligands, whereas the Her-2/neu/Her-3 was correlated with HRG ( p = 0.002), thereby indicating a functional relation between specific receptor-dimer combinations and putative ligands. Taken together, we have performed the first comprehensive survey of ErbB-system expression in breast cancer, and have demonstrated the presence of a co-regulated receptor/ligand system in vivo. We have further shown that Her-2/neu is the preferred co-expression partner in nodal-positive tumors and thus the most likely dimerization candidate in malignant breast tumors.
引用
收藏
页码:353 / 361
页数:9
相关论文
共 32 条
[1]   Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors [J].
Alimandi, M ;
Wang, LM ;
Bottaro, D ;
Lee, CC ;
Kuo, A ;
Frankel, M ;
Fedi, P ;
Tang, C ;
Lippman, M ;
Pierce, JH .
EMBO JOURNAL, 1997, 16 (18) :5608-5617
[2]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[3]  
BACUS SS, 1994, AM J CLIN PATHOL, V102, pS13
[4]  
BEERLI RR, 1995, MOL CELL BIOL, V15, P6496
[5]   Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities [J].
Beerli, RR ;
Hynes, NE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6071-6076
[6]   Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis [J].
Burden, S ;
Yarden, Y .
NEURON, 1997, 18 (06) :847-855
[7]   The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells [J].
Cohen, BD ;
Kiener, PA ;
Green, JM ;
Foy, L ;
Fell, HP ;
Zhang, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30897-30903
[8]   Active signaling by Neu in transgenic mice [J].
DiGiovanna, MP ;
Lerman, MA ;
Coffey, RJ ;
Muller, WJ ;
Cardiff, RD ;
Stern, DF .
ONCOGENE, 1998, 17 (14) :1877-1884
[9]  
DIMARCO E, 1989, ONCOGENE, V4, P831
[10]   ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling [J].
GrausPorta, D ;
Beerli, RR ;
Daly, JM ;
Hynes, NE .
EMBO JOURNAL, 1997, 16 (07) :1647-1655